Home Forums Marketplace Table of Contents Events Member List Site Map Register Mark Forums Read



Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.


Tags: ,

Multiple Sclerosis, Chemotherapy and podiatric implications.

Reply
Submit Thread >  Submit to Digg Submit to Reddit Submit to Furl Submit to Del.icio.us Submit to Google Submit to Yahoo! This Submit to Technorati Submit to StumbleUpon Submit to Spurl Submit to Netscape  < Submit Thread
 
Thread Tools Display Modes
  #1  
Old 8th November 2005, 11:45 AM
tommy tommy is offline
Podiatry Arena Rookie
 
About:
Join Date: Oct 2004
Posts: 3
Join Date: Oct 2004
Marketplace reputation 0% (0)
Thanks: 0
Thanked 0 Times in 0 Posts
Default Multiple Sclerosis, Chemotherapy and podiatric implications.

Podiatry Arena members do not see these ads
If anyone could guide me in the direction of any research work done on : -
Podiatric specific issues relating to Multiple Sclerosis and also the effects of Cancer treatment with Chemotherapy it would be appreciated.

Tommy

Last edited by tommy : 8th November 2005 at 11:59 AM. Reason: Making Grammar clearer
Reply With Quote
Sponsored Links
  #2  
Old 8th November 2005, 08:30 PM
Craig Payne's Avatar
Craig Payne Craig Payne is offline
Moderator
Professor of Life, The Universe and Everything
 
About:
Join Date: Aug 2004
Location: Melbourne, Australia
Posts: 5,018
Join Date: Aug 2004
Marketplace reputation 0% (0)
Thanks: 100
Thanked 878 Times in 604 Posts
Default

I am not aware of any...

Here is part of the notes I gave the students on MS when I taught that part of teh course:
Quote:
Clinical features:
Wide spectrum of signs, symptoms and course - depends on the location and severity of the pathological lesion(s). Typically, a young adult that trips or legs feel heavy. Most follow an initial variable relapsing and remitting course, usually with full recovery --> later remissions do not lead to full recovery.

Presenting features:
Onset in 85-90% is single symptom (depends on location of demyelination), but on careful history, there is usually a variable period of easy fatigue and low energy – optic neuritis (in 20%; usually starts as pain in eye, double vision or blurred vision; may get loss of visual acuity in one eye); diplopia (from involvement of 4th or 6th cranial nerve); sensory disturbance of the limbs (especially proprioception, parathesia, numbness or ‘leg feels heavy’; numbness may start in foot); weakness in one arm or leg (monoparesis); or weakness of both legs (paraparesis); ataxia (especially uncharacteristic tripping and incoordination of limbs – indicates cerebellar lesion); Lhermitte’s sign (sudden electric shock like sensation shooting down spine into arms or legs when patient flexes neck - thought to indicate posterior column plaques); urinary urgency and incontinence (from spinal cord involvement); severe fatigue (common disabling symptom).

Diagnosis is a generally a clinical one – confidence in diagnosis is often described as definite, probable or possible. No specific laboratory test – spinal fluid abnormalities may show autoimmune abnormalities. Evoked potentials (measure of conduction through CNS) show slowed conduction in areas of demyelination. MRI scan is sensitive in showing typical lesions and can show evidence of dissemination of lesions in both time and space.

Differential diagnosis – SLE; polyarteritis nodosa; Sjogrens syndrome; Behcet’s disease; Lyme disease; HIV; sarcoidosis; Vitamin B12 deficiency; spinocerebellar disorder; encephalomyelitis; leukodystrophies; multifocal leuckoencephalopathy

Features of established multiple sclerosis:
• motor and sensory – spinal cord involvement --> lower limb symptoms are common (heaviness, weakness, stiffness, gait problems, failure of limb to respond to ‘commands’); strength is decreased, tone increased, reflexes exaggerated (hyperreflexia), clonus, positive Babinski’s reflex, sensory loss, Lhermittes’ sign, proprioception deficits
• optic – optic neuritis (40%) --> blurring or darkening of vision, decreased colour perception, pain on eye movement; isolated cases of optic neuritis may be a forme fruste of MS
• cerebellar and brainstem (50%) – action/intention tremor, cerebellar gait disorder, dysarthric (syllabic) speech, diplopia, nystagmus, trigeminal neuralgia, hearing loss, olfactory abnormalities
• genitourinary – urinary retention, urgency, frequency, stress or overflow incontinence, sexual problems
• cognitive and emotional – in up to 50% - subcortical dementia, memory lapses, apraxia, aphasia, changed executive function, depression
• pain – in up to 50%; neurogenic in origin; dysaethetic limb pain is most common – usually burning in nature and may be due to spinal cord involvement
• fatigue – more common during attacks of MS; cause of fatigue is unknown; very disabling symptom
• impaired mobility from lower limb muscle weakness and spasticity (can be painful)
• a number of complications develop secondarily to the neurological dysfunction (eg infections, depression, contractures (from spasticity), pressure sores)

Symptoms can be aggravated by slight rise in temperature (eg fever, bathing, exercise, environmental) – even as little as 0.5 degree.

Involvement of the foot:
Cold feet are common (may only be the patients perception or may actually feel cold); weakness (foot drop); sensory symptoms; ankle oedema

Gait analysis (Gehlsen et al, 1986) has shown that those with MS have a shorter stride length, slower walking rates, higher cadence than those without MS. Also found were lower excursions for knee and ankle joints with less vertical lift of centre of gravity and a greater truck lean. Walker et al (2000) showed declines in velocity and cadence parameters over an 18 month period in 18 patients with multiple sclerosis. Base of gait in those with MS appears to be wider, presumably for increased stability.
__________________
Craig Payne
__________________________________________________ ___________________________________
Follow me on Twitter | Run Junkie | Latest Blog Post: Review of Lieberman et al’s (2010) paper in Nature on Barefoot Running
God put me on this earth to accomplish a certain number of things - right now I am so far behind, I will never die.
Reply With Quote
The Following User Says Thank You to Craig Payne For This Useful Post:
gnitram900 (9th May 2012)
  #3  
Old 9th November 2005, 08:12 AM
tommy tommy is offline
Podiatry Arena Rookie
 
About:
Join Date: Oct 2004
Posts: 3
Join Date: Oct 2004
Marketplace reputation 0% (0)
Thanks: 0
Thanked 0 Times in 0 Posts
Default

To Craig Payne
Many thanks for your reply
tommy
Thread Starter
Reply With Quote
Reply



Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Translate This Page


New To Site? Need Help?

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.


All times are GMT -7. The time now is 03:00 PM.